Mal-Lys(m-PEG4)-Val-Cit-PAB Size:50mg It has been demonstrated that

It has been demonstrated that CDg18 can be used to visualize the progressive phenotypic change of M2 toward M1 using a resveratrol analogue HS-1793 as a reprogramming effector

Gonzalez-Hernandez

Product Name BG-N3 Synonyms N-(4-((2-Amino-9H-purin-6-yloxy)methyl)benzyl)-2-azidoacetamide CAS Number Related CAS Molecular Formula C15H15N9O2 Molecular Weight 353

a Propargyl-Gly(m-PEG4) moiety replaces the conventional maleimidocaproyl (MC) unit to enhance aqueous solubility

NCCC#CC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1 Purity (HPLC) >= 95% Shipping Conditions Room temperature Storage Conditions Refrigerated Shelf Life 12 months after the date of delivery Regulatory Statement For Research Use Only

Mal-Lys(m-PEG4)-Val-Cit-PAB Size:50mg It has been demonstrated thatSOLU KNEX cleavable linker features a Val Cit dipeptide. In this product, a Mal Lys(m PEG4) moiety replaces the conventional maleimidocaproyl (MC) unit to enhance aqueous solubility. Derived from established ADC linker architectures, SOLU KNEX ADC linkers integrate solubilizing moietiessuch as PEG, amine containing groups, or polysarcosine (PSAR), to enhance aqueous solubility. Solubility and physicochemical properties can be finely tuned through